Evidence map›Paper›PMID 28587625›Full record

ArticleArthritis research & therapy2017

Anti-nuclear autoantibodies in the general German population: prevalence and lack of association with selected cardiovascular and metabolic disorders-findings of a multicenter population-based study.

Manas K Akmatov, Nadja Röber, Wolfgang Ahrens, Dieter Flesch-Janys, Julia Fricke, Halina Greiser, Kathrin Günther, Rudolf Kaaks, Yvonne Kemmling, Bastian Krone and 7 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Arthritis research & therapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Course and outcome of chilblain-like acral lesions during COVID-19 pandemic.Journal of the European Academy of Dermatology and Venereology : JEADV · 2023
    Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 10 institutions in 1 country.

Manas K AkmatovTWINCORE, Centre for Experimental and Clinical Infection Research, Feodor-Lynen-Straße 7, 30625, Hannover, Germany. manas.akmatov@twincore.de.
Nadja RöberInstitute of Immunology, Technical University Dresden, Dresden, Germany.
Wolfgang AhrensLeibniz Institute for Prevention Research and Epidemiology-BIPS, Bremen, Germany.
Dieter Flesch-JanysUniversity Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Julia FrickeGerman Cancer Research Center (DKFZ), Heidelberg, Germany.
Halina GreiserGerman Cancer Research Center (DKFZ), Heidelberg, Germany.
Kathrin GüntherLeibniz Institute for Prevention Research and Epidemiology-BIPS, Bremen, Germany.
Rudolf KaaksGerman Cancer Research Center (DKFZ), Heidelberg, Germany.
Yvonne KemmlingDepartment of Epidemiology, Helmholtz Centre for Infection Research, Braunschweig, Germany.
Bastian KroneInstitute for Medical Informatics, Biometry and Epidemiology (IMIBE), University Clinics of Essen, Essen, Germany.
Jakob LinseisenHelmholtz Zentrum München, Institute for Epidemiology II, Neuherberg, Germany.
Christa MeisingerHelmholtz Zentrum München, Institute for Epidemiology II, Neuherberg, Germany.
Susanne MoebusInstitute for Medical Informatics, Biometry and Epidemiology (IMIBE), University Clinics of Essen, Essen, Germany.
Nadia ObiUniversity Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Carlos A GuzmanDepartment of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research, Braunschweig, Germany.
Karsten ConradInstitute of Immunology, Technical University Dresden, Dresden, Germany.
Frank PesslerTWINCORE, Centre for Experimental and Clinical Infection Research, Feodor-Lynen-Straße 7, 30625, Hannover, Germany.
Center for Experimental and Clinical Infection Research · DEHelmholtz Centre for Infection Research · DEHelmholtz Zentrum München · DEInstitut für Medizinische Informatik, Biometrie und Epidemiologie · DELeibniz Institute for Prevention Research and Epidemiology - BIPS · DETU Dresden · DEUniversität Hamburg · DECharité - Universitätsmedizin Berlin · DEGerman Cancer Research Center · DEHeidelberg University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe determined the prevalence of anti-nuclear autoantibodies (ANAs) in the German adult population and examined the association between ANAs and cardiovascular and metabolic disorders.

methodsWe used data and blood samples from the pretest phases of the German National Cohort, obtained from six of the 18 study centers (n = 1199). All centers applied standardized instruments including face-to-face interviews, anthropometric measurements and collection of blood samples. Self-reported histories of diabetes mellitus, heart attack and elevated blood cholesterol and/or lipids were recorded. Height, weight and blood pressure were measured. ANAs were detected using a semi-automated system (AKLIDES®; Medipan GmbH, Dahlewitz, Germany). A positive ANA was defined as a titer ≥ 1:80. ANA were classified as weakly (1:80 or 1:160), moderately (1:320 or 1:640) or strongly (≥1:1280) positive. Specific autoantibodies against nuclear antigens were detected with second-step assays according to the ANA staining pattern. Associations between the assessed disorders and ANA positivity and pattern were examined using sex and age-adjusted mixed-effects logistic regression models.

resultsThirty-three percent (95% confidence interval; 31-36%) of the 1196 participants (measurements could not be obtained from three samples) were ANA positive (titer ≥ 1:80). The proportions of weakly, moderately and strongly positive ANA were 29%, 3.3% and 1.3%, respectively. ANA positivity was more common among women than men across all titers (χ

conclusionsThe prevalence of ANA positivity in the German general population was similar to values reported from other countries. Contrary to other studies, there was no association with selected self-reported and objectively measured cardiovascular and metabolic variables.

Indexed as

AdultAgedAntibodies, AntinuclearCardiovascular DiseasesCohort StudiesFemaleGermanyHumansLipidsLogistic ModelsMaleMetabolic DiseasesMiddle AgedPopulation SurveillancePrevalenceYoung AdultAntibodies, AntinuclearLipidsAnti-nuclear autoantibodiesDiabetesGerman National CohortHypertensionMetabolismObesityPopulation-based study

Identifiers

PMID28587625
PMCPMC5461675
OpenAlexW2623351128

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.